Fill and Finish Solutions

Fill and finish operations represent the critical final step before therapeutic products reach patients, demanding precision, quality, and regulatory compliance. Sartorius addresses these challenges through an integrated portfolio of single-use technologies designed specifically for biopharmaceutical manufacturing environments.

The comprehensive solution encompasses drug substance receipt and thaw using Celsius^® FFT containers with innovative bag-in-plate design, ensuring controlled thawing and exceptional protection during frozen storage. Advanced mixing capabilities through Flexsafe® Pro Mixer technology deliver high-performance powder dissolution with levitating impeller systems, preserving drug integrity during low-shear blending applications across scales from 5 L to 1,000 L.

Sterile filtration operations benefit from Sartopore Evo® filters featuring surface-coated PES membranes that minimize protein and excipient adsorption while maintaining high throughput. Pre-configured filter transfer sets reduce design phase wait times by up to 80% and comply with PUPSIT requirements outlined in EU GMP Annex 1. Automated integrity testing systems further reduce operator errors during manual processing.

Aseptic transfer capabilities include Biosafe® Rapid Transfer Port systems with magnetic docking technology and SART System™ solutions for error-proof liquid transfer across cleanroom classifications. These systems maintain sterility while enabling gloveless interventions and total containment after closure.

Final filling applications utilize Octoplus FF^® and Flexsafe^® 2D Advanced FF^® systems, offering 99.5% product recovery through optimized wallet-shape bag designs. Individual filling lines on flat bag bottoms accommodate multiple filling line configurations while eliminating CIP/SIP validation requirements in ISO 5 environments.

Confidence® Validation Services provide comprehensive support across the entire validation lifecycle, from protocol development to final documentation and audit readiness. Risk-based validation approaches focus on critical parameters while global regulatory expertise helps navigate regional requirements and agency expectations. In-house laboratories enable faster turnaround times and greater flexibility in test method development.

The integrated approach combines proven single-use technologies with regulatory expertise and hands-on collaboration, enabling manufacturers to protect product quality, streamline operations, and scale with confidence across high-value biologics and advanced therapy applications.